KAMPALA – The Dei BioPharma manufacturing facility in Matugga, Wakiso District, has officially commenced production of pharmaceutical products, marking a major milestone in Uganda’s drive to develop its local biotechnology...

The U.S. Food and Drug Administration (FDA) has accepted an application from Uganda’s Dei BioPharma for the review of its Abbreviated New Drug Application (ANDA) for liraglutide, a multibillion-dollar treatment...